Vous êtes sur la page 1sur 23

karRbyuTkarBarCmWminqg

NON COMMUNICABLE DISEASES PREVENTION


AND CONTROL

evCbNit R)ak; BisidrgSI


GnubNitsuxPaBsaFarN - keTsGaharUbtmnigrbbGahar

lTplrMBwgTuk

Expected outcome

emeronenH bgajnisiSteGaydwgBI
niymnynCmWminqg
TMhMnbBaa
eGBIedmIsaRsnCmWminqg
ktaeRKaHfak;EdlbNaleGayekItCmWminqg
viFIsaRsTUeTAsRmab;RbyuTkarBarCmWminqg
cugbBab;nemeronenH nisiStnwg)andwgc,as;BI CmWminqgmYycMnYnEdlGackarBar)aneday
karpas;br\riyabfnigkarRbRBwtrbs;buKlpal;

niymny Definition
CmWminqgKWCaCmWEdlQaneTArkPaBraMr:ebIminBa)alTan;eBlevla ehIyekIteLIgmk BIkta
CaeRcIn dUcCa emtabUlIk karbriePaKGaharelIskMNt; GaharKanKuNPaB karbMBulbridan
edayfaMsMlab;stVlit CIKImIbegInePaKpl )arI Rsa nig emeraKmYycMnYn kb:uEnmincMlgBI
mnusSmak;eTAmnusSmak;eLIy .
CmWminqgEdlEtgEtCYbRbTHeRcInCageKKW CmWTwkenamEpm CmWebHdUgssQam CmWxYrk,al
ssQam CmWmharIk CmWsYt CmWefIm CmWtRmgenam CmWRkBHeBaHevon CmWkgVHCIvCatinig
GaharrUbtm CmWpvcit rbYsedayeRKaHfak;cracrnigeRKaHfak;dTeTot .

TMhMnbBaa Magnitude of the Problem


mnusSTUTaMgsklelakminfakgu RbeTsGPivDnbk kMBg;GPivDn)anCYb
RbTHnUvCMgWminqgKYr eGaykt;sM Kal;CaBiessKWenAkg RsTab;RbCaCn
EdlmancMNUlTabnigmFm
karvivDnrbs;sgmCatiTaMgmUl TaMgEpkesdkicnigviTasaRs)an
eFVeI GaymankarERbRblBI CMgWqgeTACaCMgWmni qg
karelcnUvCMgWminqgEdlCaCMgWraMr: )anekIneLIgTUTaMgsklelak
GRtasab); anedIrQanmuxeK
karGPivDnnUvbeckeTsviTasaRsTMenIb karbMBulbridaneFVeI Gay
EpndInBiPBelakERRbYl eFVIeGayb:HBal;dl;suxPaB RbCaCn
EdlTaMgenHCamUlehtunkarbrTisBICgM Wqg mkCMgWminqg
naeBlbcb ,n GgkarsuxPaBBiPBelak)aneFVIkar)a:n;RbmaNBICMgW
minqgmanRbEhl 43 nig 59 )ansab;edaysarCMgWenAkgskl
elakehIy)anTsSnTayfaCMgWmni qgTaMgenHnwgekIndl; 60 enAqaM
2020.

eGBIedmIsaRs Epidemiology
26 500 nak;)ansab;edaysarCmWminqgCaerog ral;fenAtMbn;
GasIu)asIhu VkI
kgcMeNamFksab;10nak;man7nak;Edlsab; edaysarCmWmni qg
1 PaK2 nGksab;TaMgenaH KWzitkgGayueRkam 70qaM ehIyPaK
eRcInKWsab;edaysarCmmW harIk nigCmWebHdUg eRcInCag sab;eday
CmqW gTaMgGs;
GkCmWmharIkKWRtUvsab;munGayukalelIsBI 25 nCIvti rbs;Kat;
edaysarCMgW DALYs/ GkCmWpv degIm 33/ GkCmWTwkenam
Epm nigCmeW bHdUg 20
PaB)at;bg;fvikadeRcIncMeBaHGkCmWmni qg edaysarfBa)al nig
karGak;xaneFVkI argar

krNIsab; tammUlehtukgtMbn;rbs;GgkarsuxPaBBiPBelak
Deaths, by broad cause group and WHO Region, 2000
%
75

50

25

AFR

EMR

SEAR

Noncommunicable
conditions

WPR
Injuries

AMR

EUR

Communicable diseases, maternal


and perinatal conditions and
nutritional deficiencies

GRtaeRbv:aLg;tamsg;darGayunCMgWTwkenamEpmcab;BIGayu25qaMeLIg qaM2008
Age-standardized prevalence of diabetes mellitus in adults aged 25+ years,
comparable estimates, Western Pacific Region, 2008

GRtaGaMgsIusg;tamsg;darGayunCMgWmharIkelIkElgEtmharIkEs,k qaM2008
Age-standardized incidence rate of cancer (all sites except non-melanoma skin
cancer), Western Pacific Region, 2008

Source: IARC Globocan 2008

GRtasab;tamsg;darGayunCMgWminqgkgcMeNamRbCaCn 100000 qaM2008


Age-standardized death rate (per 100 000) from NCD, Western
Pacific Region, 2008

GRtasab;tamsg;darGayunCMgWebHdUgnigTwkenamEpmkgcMeNamRbCaCn 100000 qaM2008


Age-standardized death rate (per 100 000) from cardiovascular disease and
diabetes, Western Pacific Region, 2008

GRtasab;tamsg;darGayunGkCMgWmharIkkgcMeNamRbCaCn 100000 qaM2008


Age-standardized death rate (per 100 000) from Cancer, Western
Pacific Region, 2008

vIFIsaRsTUeTAsMrab;RbyuTkarBarnwgCMgWminqg


Helping to improve health

KNOWLEDGE BEHAVIOUR PARADOX

Behavioral intention


Behavior change


( -
- - )

-
-
-
-
-
- -
-

Knowledge+




ENABLING ENVIRONMENT FOR HEALTHY LIVING and HEALTHIER CHOICES


/
/

Meet their primary interest NCD prevention can be a co-benefit



Education


Agriculture

Industries

Urban planning

viFIsaRscMbgnkarkarBar
ral;krNInCMgWminqg viFankarkarBarTb;sat;mineGayekItmannigkarvivtne TArkPaBraMur:)anKWGaRsyeTA
elIkaryk citdak;BIsgmCatinimYy nigbuKlxngpal;pg.
esckBI ayam PaBGMNt;kg karrkSanUvrbb Gahar \riyabfkgkarbriePaK karhat;R)aNeTogTat;
Gackat;bny nUvGRtaCMgrW aMur:ngi GRtasab;)an RbEhl50 .
ebIeRBobeFobBItMlRbsiTPaBnviFankarkarBarnigkarBa)alvij eXIjfa : karBarRbesICagBa)al :
eRBaHkareRbIR)as; fvikacMNayelIkarkarBarmantMlefakCagkarBa)alEdlRtUveRbIR)as;sfsmarbrika
nigFnFanmnusSeRcIn kb:uEn viFankarkarBarktMrUvnUvbeckviTaTMenIb
bTBiesaFnngi PaBGMNt;kgu karRsavRCavpgEdr.
viFankarkarBarKWmanbItMNak;kalepSgKa
1- tMNak;kalTImyY nkarkarBar
2- tMNak;kalTIBIrnkarkarBar
3- tMNak;kalTIbInkarkarBar

tMNak;kalTImYynkarkarBar
KWCaskmPaBTb;sat;CMgWTukCamun EdleFVCI alkNTUeTAcMeBaHmnusSRKb;rbU eTaHbICaBYkeK mansuxPaBl
BMTu an;elcecjnUveraKsBaaGVmI YyKYreGaykt;sMKal; kb:Eu ntrM UveGayBinti suxPaBCaRbcaM Biesscab;BGI ayu
35eLIgeTA ya:gehacNas;keGay)anmYydgEdrkg mYyqaM.
EbbbTn karBinti suxPaB
burs KYrBinti EPk RcmuH bMBg;kr sYt ebHdUg sma<FQam nigBinitQamrkemIl eGma:tURKIt Catisr Catixaj;
kUelsesrU:l RTIKIe srIt nig GasIuteGorIc edIm,IRsavRCavrkemIlPaBminRbRktInsrIrag.
RsI Binti dUcbursEdr kb:uEnBinti bEnm s,n mat;s,n nig Binti edaH edIm,IRsavRCavrkkarrlakmat;s,n
rlaks,n nigmandMsu ac;Bk karBarCMgmW harIk. ma:gvijeTot cMeBaHRsmI anpeBaH tMrUveGayBinti emIl
karlUtlas;rbs;Tarkkgp Cab;CaRbcaMtamkarkMNt;rbs;RKUeBTedIm,IrkemIlnUvsBaaeRKaHfak; nigcak;faM
bgarettaNUs.

tMNak;kalTImYynkarkarBar
CamYyKaenHEdr viFIkarBarepSgeTotdUcCakarhat;R)aN ya:gehacNas;eGay)anknHema:gkg mYyf Gac
kat;bnynUvktargeRKaHedayCMgWssQamebHdUg CMgTW kw enamEpmnigkareLIgTMgn; .
karhat;R)aNnigkar sMrkTMgn;GacbnynUvkMrtw LDL, Cholesterol, HDL, Triglycerides bnysma<FQam
nigGaMgsIlu In Gacbnysma<FQammkFmtavijenAeBlhat;R)aN)anBIrdgkgmYyf kb:uEnvaGaRsy
eTAelIlkNn karhat;R)aN karERbRbYlrbs;buKl nimYypgEdr.
tamkarRsavRCavrbs;elak Thomson karhat;R)aN )ankat;bnyGaMgsIlu Insa nigkarminGacTTYlykCati
sr)an kareLIgCatisrmuneBlbriePaK Insulin resistance, glucose intolerance nigkarbeBaj Catisr
BIefmI .
skmPaBCaeRcInnkayvb,kmGac RtYtBinti TMgn;xn)an.

tMNak;kalTImYynkarkarBar
karRbtibtinUvrbbGaharRtwmRtUv rYmman
RtUveFVIya:gNaeGaymantulPaBrvagfamBlnigTMgn;EdlRtwmRtUvtamk,nevCsaRs
RtUvkMrwtfamBlEdl)anmkBIkarbriePaKCatixaj; ( total fats shift fats ) nigeCos eGayqay
BIkarbriePaKCatixaj; ( saturated fats to unsaturated fats ) Edleqa<HeTAbM)at; ( trans-fatty acids )
RtUvbegInkarbriePaK bEn EpeQI nigRKab;FBaCatiepSg eGay)aneRcIn
RtUvbnykarbriePaKsrpal;bbEgmEpeQIEdlEpmxaMg
RtUvbnykarbriePaKGaharEdlmanCatiRbxaMg ehIyGMbwlRtUvEtmanlayCatiGIuyUt

tMNak;kalTIBIrnkarkarBar
Secondary Prevention
manTisedACacMbgKWsMedARsavRCavrkeGayeXIjnUvCMgWkg cMeNamRbCaCnEdlBMTu an;)an beBajeGaydwgxn
famanCMgW kb:uEnsamIxn )anRbQmnwgktahaniPyrYcehIy krNIenHkic GnraKmn_RtUveFVeI dIm,Ikat;bny
GRtasab; nigbgarplvi)akEdlbgredaysarCMgW ehIykar cMNaymanRbsiTPaB.
rebobRsavRCavrkCMgW (Screening)
RsavRCavkgcMeNamRbCaCn eqa<HeTAelIkarRsavRCaveGBIedmIsaRs rkeRbva:Lg;CgM W vaytMlkta haniPy
edIm,IeFVIEpnkarsuxaPi)al Tb;sat;nigkarBarTan;eBl.
RsavRCavedayeFVkI areRCIserIs KW sMedARkumcMNucEdlcg;)an nigtMNageGaylkNbBaak;BIPaB
RbQmmuxxagM ka dUcCa ktaBCU sasn_ ktasYrBUC ktaGayuePT ktahaniPy bgrCMgW .l.
RsavRCavkg eBlGtifiCnmkBieRKaHCMgW KWCaviFIEdleKeRbIeRcInCageK eRBaHvamin)ancMNayR)ak;
kgkardwknaMkarRsavRCav nigmin)anehAGtifiCneGaymk.

tMNak;kalTIbInkarkarBar
Tertiary Prevention

KWkarBa)alEfTaMGkCMgWedIm,ITb;sat;karBarmineGaymanplvi)akRsYc
RsavnigraMr: nigBikarPaB EdlCa bBaab:HBal;dl;esdkic sgm.
tMNak;TIbInkarkarBarenH KWtMrUveGaymankarBa)alnigtamdanlitln;
nigkarGb;rMsuxPaB RBmTaMgkarsarlTPaBBlkmpgEdr.

Vous aimerez peut-être aussi